Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2022

May 16, 2022

62616_rns_2022-05-16_6d3e1233-46a8-43bc-903e-38d209d929d1.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

May 16, 2022

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 532531

Dear Sirs,

Re: Announcement of Board Meeting under Regulation 29 of SEBI Listing Regulations

This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, May 24, 2022 to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2022 and recommendation of dividend, if any, amongst other matters.

Further, as per the provisions of the Company’s Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company.

This is for your kind information and record purposes.

Thanks & Regards,

For Strides Pharma Science Limited,

==> picture [115 x 52] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [85 x 83] intentionally omitted <==

==> picture [479 x 52] intentionally omitted <==